Dr Reddy's Lab gets EIR for Srikakulam facility from USFDA

26 Aug 2022 , 09:18 AM

Dr Reddy’s Laboratories Limited has further informed to the exchanges on the inspection conducted by the United States Food & Drug Administration (USFDA) at its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.

The company informed that it has received the Establishment Inspection Report (EIR) from USFDA for its Srikakulam facility. 

It further informed that now, the Agency has concluded that the inspection is finally ‘closed’.

At around 9:18 AM, Dr Reddys Laboratories Ltd is currently trading at Rs4,240.45 per share down by Rs0.75 or 0.02% from its previous closing of Rs4,241.20 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]